Clinical Translation of Basic Research

Advancing our drugs and technologies to human clinical trials

We work in various phases of drug discovery, including validation of new drug targets, design and delivery of drugs, and development of detection technologies that assist with the diagnosis and monitoring of treatment.

Several compounds developed by our researchers, often in collaboration with pharmaceutical companies or federal agencies, are already being used in the marketplace to treat chronic and acute illness. Many others are undergoing clinical trials in the United States and beyond. Right now, clinical trials of Purdue-initiated drugs are underway in more than 150 research hospitals around the world, including the National Cancer Institute, Indiana University School of Medicine and Mayo Clinic.

Currently, our researchers are working on several classes of compounds and novel approaches to drug design. The figure below summarizes the active stages of drug discovery at Purdue.